Two Sigma Advisers’s Spero Therapeutics SPRO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-176,157
| Closed | -$131K | – | 2717 |
|
2022
Q2 | $131K | Buy |
176,157
+159,757
| +974% | +$119K | ﹤0.01% | 2357 |
|
2022
Q1 | $143K | Buy |
+16,400
| New | +$143K | ﹤0.01% | 2441 |
|
2021
Q2 | – | Sell |
-24,528
| Closed | -$361K | – | 2679 |
|
2021
Q1 | $361K | Buy |
24,528
+5,200
| +27% | +$76.5K | ﹤0.01% | 2152 |
|
2020
Q4 | $375K | Sell |
19,328
-2,100
| -10% | -$40.7K | ﹤0.01% | 1972 |
|
2020
Q3 | $239K | Buy |
21,428
+5,100
| +31% | +$56.9K | ﹤0.01% | 2100 |
|
2020
Q2 | $221K | Buy |
+16,328
| New | +$221K | ﹤0.01% | 2214 |
|